This company seems to have been delisted
Reason: Liquidation
Last recorded trade on: February 20, 2025
Source: https://globalgenes.org/raredaily/bellerophons-board-agrees-to-liquidate-after-trial-failures-and-layoffs/
Reason: Liquidation
Last recorded trade on: February 20, 2025
Source: https://globalgenes.org/raredaily/bellerophons-board-agrees-to-liquidate-after-trial-failures-and-layoffs/
Bellerophon Therapeutics
BLPH
₹1.03
Share price
-36.84%
Change (1 day)
-79.46%
Change (1 year)
Categories
Bellerophon Therapeutics (BLPH) - Total assets
Total assets on the balance sheet as of September 2023 : ₹0.42 Billion
According to Bellerophon Therapeutics 's latest financial reports the company's total assets are ₹0.42 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Bellerophon Therapeutics - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | ₹0.65 B | -67.17% |
| 2021-12-31 | ₹2.00 B | -45.56% |
| 2020-12-31 | ₹3.67 B | 293.07% |
| 2019-12-31 | ₹0.93 B | -27.19% |
| 2018-12-31 | ₹1.28 B | -45.38% |
| 2017-12-31 | ₹2.35 B | 16.45% |
| 2016-12-31 | ₹2.01 B | -20.92% |
| 2015-12-31 | ₹2.55 B | 20.61% |
| 2014-12-31 | ₹2.11 B | 842.1% |
| 2013-12-31 | ₹0.22 B | 22.5% |
| 2012-12-31 | ₹0.18 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Baxter BAX | ₹1.827 T | 427,777.08% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | ₹8.52 B | 1,895.66% | 🇺🇸 USA |
 Abbott Laboratories ABT | ₹6.986 T | 1,635,730.49% | 🇺🇸 USA |
 Lantheus Holdings LNTH | ₹176.28 B | 41,177.77% | 🇺🇸 USA |